Goldman Sachs maintained a Sell rating on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a price target of $27. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) net profit margin is -82.20% and weekly performance is -3.98%. On last trading day company shares ended up $30.40. Analysts mean target price for the company is $71.36. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) distance from 50-day simple moving average (SMA50) is -24.44%.
Oil States International Inc. (NYSE:OIS) was upgraded by Sterne Agee from a “neutral” rating to a “buy” rating in a research note issued on Monday. Oil States International, Inc. (NYSE:OIS) shares fell -42.73% in last trading session and ended the day on $61.61. OIS gross Margin is 37.70% and its return on assets is 12.10%.Oil States International, Inc. (NYSE:OIS) quarterly performance is -35.09%.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) management will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 at 9:00 AM EDT in New York City. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares moved down -4.55% in last trading session and was closed at $1.26, while trading in range of $1.26 – $1.33. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) year to date (YTD) performance is -30.00%.
Francesca’s Holdings Corporation (NASDAQ:FRAN) announced plans to report first quarter fiscal year 2014 financial results on Tuesday, June 10, 2014, before the market opens. The Company also plans to hold a conference call to discuss its financial results the same day at 8:30 a.m. ET. Francesca’s Holdings Corp (NASDAQ:FRAN) ended the last trading day at $15.06. Company weekly volatility is calculated as 3.41% and price to cash ratio as 16.96.Francesca’s Holdings Corp (NASDAQ:FRAN) showed a negative weekly performance of -6.28%.
Propanc Health Group Corporation (OTCMKTS:PPCH) an emerging healthcare company focused on the development of new and proprietary treatments for cancer patients, on 23 may announced that it has made substantial progress in connection with their ongoing efforts to secure acceptance and approval of patent applications filed around the world. On last trading day company shares ended up $0.260.
Leave a Reply